The FDA reviewed specific genetic engineering products and published views on the issues surrounding them.
1 report, 1 independent
Updated Jun 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA reviewed specific genetic engineering products and published views on the issues surrounding them.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- FDA placed a clinical hold on a gene therapy involving Hunter.
- Solid Biosciences received FDA approval for a gene therapy trial on July 9, 2025.
- The FDA reviewed gene therapy applications and provided milestone payments for dosing involving Regenxbio and AbbVie.
- The FDA was tasked to review product licenses and public health warnings.
- FDA and Pfizer are seeking regulatory approval for their products.